$DORM
Dorman Products, Inc.

2021 Q1 Form 10-Q Financial Statement

#000156459021020548 Filed on April 26, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $288.0M $257.7M
YoY Change 11.75% 5.72%
Cost Of Revenue $183.5M $172.9M
YoY Change 6.13% 10.62%
Gross Profit $104.5M $84.80M
YoY Change 23.23% -3.09%
Gross Profit Margin 36.28% 32.9%
Selling, General & Admin $62.90M $59.70M
YoY Change 5.36% 3.38%
% of Gross Profit 60.19% 70.4%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.300M $7.500M
YoY Change -2.67% 2.74%
% of Gross Profit 6.99% 8.84%
Operating Expenses $62.90M $59.80M
YoY Change 5.18% 3.55%
Operating Profit $41.60M $25.06M
YoY Change 65.99% -15.74%
Interest Expense $121.0K
YoY Change
% of Operating Profit 0.29%
Other Income/Expense, Net $85.00K $2.631M
YoY Change -96.77% 8972.41%
Pretax Income $41.62M $27.69M
YoY Change 50.27% -6.98%
Income Tax $8.885M $4.918M
% Of Pretax Income 21.35% 17.76%
Net Earnings $32.73M $22.78M
YoY Change 43.71% -2.7%
Net Earnings / Revenue 11.36% 8.84%
Basic Earnings Per Share $1.02 $0.70
Diluted Earnings Per Share $1.02 $0.70
COMMON SHARES
Basic Shares Outstanding 32.05M 32.35M
Diluted Shares Outstanding 32.18M 32.43M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $166.6M $161.8M
YoY Change 2.97% 296.57%
Cash & Equivalents $166.6M $161.8M
Short-Term Investments
Other Short-Term Assets $9.800M $10.80M
YoY Change -9.26% 45.95%
Inventory $337.7M $258.4M
Prepaid Expenses
Receivables $452.5M $423.3M
Other Receivables $0.00 $0.00
Total Short-Term Assets $966.6M $854.3M
YoY Change 13.15% 34.62%
LONG-TERM ASSETS
Property, Plant & Equipment $130.3M $99.08M
YoY Change 31.51% -2.28%
Goodwill $91.28M
YoY Change 25.72%
Intangibles $27.75M
YoY Change 12.51%
Long-Term Investments
YoY Change
Other Assets $51.90M $44.30M
YoY Change 17.15% -16.72%
Total Long-Term Assets $297.7M $298.5M
YoY Change -0.28% 1.92%
TOTAL ASSETS
Total Short-Term Assets $966.6M $854.3M
Total Long-Term Assets $297.7M $298.5M
Total Assets $1.264B $1.153B
YoY Change 9.67% 24.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $118.5M $73.28M
YoY Change 61.7% -25.44%
Accrued Expenses $216.9M $142.3M
YoY Change 52.42% 384.64%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $99.00M
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $335.4M $314.5M
YoY Change 6.64% 134.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $41.30M $13.30M
YoY Change 210.57% -6.42%
Total Long-Term Liabilities $41.30M $13.30M
YoY Change 210.57% -6.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $335.4M $314.5M
Total Long-Term Liabilities $41.30M $13.30M
Total Liabilities $380.5M $327.8M
YoY Change 16.06% 121.32%
SHAREHOLDERS EQUITY
Retained Earnings $815.9M $737.6M
YoY Change 10.62% 6.67%
Common Stock $67.92M $53.78M
YoY Change 26.29% 7.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $883.8M $791.4M
YoY Change
Total Liabilities & Shareholders Equity $1.264B $1.153B
YoY Change 9.67% 24.29%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $32.73M $22.78M
YoY Change 43.71% -2.7%
Depreciation, Depletion And Amortization $7.300M $7.500M
YoY Change -2.67% 2.74%
Cash From Operating Activities $21.02M $18.59M
YoY Change 13.07% 13.14%
INVESTING ACTIVITIES
Capital Expenditures $6.207M $3.505M
YoY Change 77.09% -60.34%
Acquisitions $14.46M
YoY Change
Other Investing Activities $0.00 -$14.50M
YoY Change -100.0%
Cash From Investing Activities -$6.207M -$17.97M
YoY Change -65.45% 103.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.786M 92.80M
YoY Change -104.08% -1004.77%
NET CHANGE
Cash From Operating Activities 21.02M 18.59M
Cash From Investing Activities -6.207M -17.97M
Cash From Financing Activities -3.786M 92.80M
Net Change In Cash 11.03M 93.43M
YoY Change -88.2% -3606.94%
FREE CASH FLOW
Cash From Operating Activities $21.02M $18.59M
Capital Expenditures $6.207M $3.505M
Free Cash Flow $14.81M $15.09M
YoY Change -1.8% 98.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y8M12D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y8M12D
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155576000
CY2021Q1 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
1210000
CY2020Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
1260000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
460878000
CY2020Q4 us-gaap Inventory Net
InventoryNet
298719000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7758000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
922931000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
91009000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
39552000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
39002000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10040000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9194000
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12173000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12450000
CY2021Q1 dorm Accrued Customer Rebates And Returns
AccruedCustomerRebatesAndReturns
163967000
CY2020Q4 dorm Accrued Customer Rebates And Returns
AccruedCustomerRebatesAndReturns
155751000
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
39752000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
29305000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
335417000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
322645000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37226000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37083000
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3748000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3819000
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
321000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
322000
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
67596000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
64085000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
815894000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
789152000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
883811000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
853559000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1264269000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1220661000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
853559000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
316000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2111000
CY2021Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3974000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-931000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
32730000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
773584000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1214000
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
5780000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
32730000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
22775000
CY2021Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
7267000
CY2020Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
7496000
CY2020Q1 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
2498000
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
18000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
14000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-912000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2111000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1214000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
7600381000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8338000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
29491000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
38978000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-28016000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2017000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2262000
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1270000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2219000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
737000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-19346000
CY2021Q1 dorm Increase Decrease In Accrued Customer Rebates And Returns
IncreaseDecreaseInAccruedCustomerRebatesAndReturns
8215000
CY2020Q1 dorm Increase Decrease In Accrued Customer Rebates And Returns
IncreaseDecreaseInAccruedCustomerRebatesAndReturns
4471000
CY2021Q1 dorm Increase Decrease In Accrued Compensation And Other Liabilities
IncreaseDecreaseInAccruedCompensationAndOtherLiabilities
3869000
CY2020Q1 dorm Increase Decrease In Accrued Compensation And Other Liabilities
IncreaseDecreaseInAccruedCompensationAndOtherLiabilities
6808000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21020000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18590000
CY2020Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
14462000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6207000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3505000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6207000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17967000
CY2020Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
99000000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
289000
CY2021Q1 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-932000
CY2020Q1 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-418000
CY2021Q1 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
3143000
CY2020Q1 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
5780000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3786000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
92802000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11027000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
93425000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
155576000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
68353000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
166603000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
161778000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
77000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
20000
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
167000
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
62000
CY2020Q4 us-gaap Inventory Net
InventoryNet
298719000
CY2020Q1 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
151300000
CY2021Q1 dorm Maximum Credit Terms Allow To Customers
MaximumCreditTermsAllowToCustomers
P365D
CY2021Q1 us-gaap Inventory Net
InventoryNet
337697000
CY2021Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
8000000.0
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
8000000.0
CY2021Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
15600000
CY2021Q1 dorm Maximum Credit Terms Allow To Customers
MaximumCreditTermsAllowToCustomers
P365D
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
288012000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
257730000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
288012000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
257730000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
217735
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
72.77
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
44976
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
113.10
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
24011
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
63.37
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
39256
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
74.30
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
199444
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
82.69
CY2021Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
300000
CY2020Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
200000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
250779
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
70.21
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
55794
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
101.45
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
31802
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
64.07
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
274771
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
77.26
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
94618
CY2021Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
73.61
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2991137000
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
91273
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
32730000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
22775000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32048000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32354000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
136000
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
72000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32184000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32426000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.02
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1100000
CY2020 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1800000
CY2021Q1 dorm Lease Effective Date
LeaseEffectiveDate
2018-01-01

Files In Submission

Name View Source Status
0001564590-21-020548-index-headers.html Edgar Link pending
0001564590-21-020548-index.html Edgar Link pending
0001564590-21-020548.txt Edgar Link pending
0001564590-21-020548-xbrl.zip Edgar Link pending
dorm-10q_20210327.htm Edgar Link pending
dorm-10q_20210327_htm.xml Edgar Link completed
dorm-20210327.xsd Edgar Link pending
dorm-20210327_cal.xml Edgar Link unprocessable
dorm-20210327_def.xml Edgar Link unprocessable
dorm-20210327_lab.xml Edgar Link unprocessable
dorm-20210327_pre.xml Edgar Link unprocessable
dorm-ex311_10.htm Edgar Link pending
dorm-ex312_9.htm Edgar Link pending
dorm-ex32_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gmb2550slvff000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending